文献速递心脑血管急症重症综合管理与镇静镇痛

COVID-19危重患者神经血液生物标志物的定量分析

Quantification of Neurological Blood-Based Biomarkers in Critically Ill Patients With Coronavirus Disease 2019.
PubMed 文献 · Crit Care Explor · 2020-10-02
一句话结论COVID-19危重患者血浆GFAP较其他病因肺炎ICU对照高约两倍,GFAP、UCH-L1、NfL与谵妄相关且独立于呼吸功能和外周细胞因子。

这项多中心前瞻性观察研究纳入27例COVID-19呼吸衰竭危重患者和19例ICU对照,检测血浆神经丝轻链、总tau、泛素羧基末端水解酶L1和胶质纤维酸性蛋白。COVID-19组GFAP显著高于其他病因肺炎ICU对照(272 pg/mL vs 118 pg/mL,p=0.0009)。在COVID-19组中,GFAP、UCH-L1、NfL与ICDSC评分正相关,且在谵妄(ICDSC≥4)患者中升高,但ICU对照组无此关联。这些标志物升高与呼吸功能指标及细胞因子无关联。

要点

  • COVID-19危重患者血浆GFAP为272 pg/mL(150-555 pg/mL),显著高于其他病因肺炎ICU对照的118 pg/mL(78.5-168 pg/mL),p=0.0009。
  • COVID-19组中GFAP(rho=0.5115,p=0.0064)、UCH-L1(rho=0.4056,p=0.0358)、NfL(rho=0.6223,p=0.0005)与ICDSC评分正相关。
  • COVID-19组谵妄(ICDSC≥4)患者GFAP、UCH-L1、NfL升高,而ICU对照组无此关联。
  • COVID-19患者中GFAP、总tau、UCH-L1、NfL水平与呼吸功能指标或细胞因子均无关联。
  • 该研究为前瞻性观察性多中心ICU研究,样本量27例COVID-19和19例ICU对照,结果需进一步验证。

适用人群与场景

  • ICU中因呼吸衰竭需要重症监护的COVID-19危重患者;ICU对照组为其他病因肺炎导致呼吸衰竭的危重患者。
  • 研究在多中心ICU进行,纳入标准为危重呼吸衰竭患者,排除标准原文未提及。

诊断标准与关键阈值

  • 谵妄评估采用重症监护谵妄筛查量表(Intensive Care Delirium Screening Checklist,ICDSC),量表范围1-8分,谵妄定义为ICDSC≥4分。
  • 原文未提及其他诊断标准或生物标志物阈值。

处置流程与药物剂量

  • 原文未提及

红旗征与不能漏的情况

  • 原文未提及红旗征或需要立刻处理的情况。

研究设计与关键结果

  • 研究类型:前瞻性观察性研究,多中心ICU,纳入27例COVID-19危重呼吸衰竭患者和19例ICU对照(其他病因肺炎)。
  • 主要神经结局为谵妄(ICDSC 1-8分,谵妄定义为ICDSC≥4)。
  • COVID-19组GFAP为272 pg/mL(150-555 pg/mL),ICU对照组为118 pg/mL(78.5-168 pg/mL),p=0.0009。
  • COVID-19组中GFAP与ICDSC评分正相关(rho=0.5115,p=0.0064),UCH-L1与ICDSC正相关(rho=0.4056,p=0.0358),NfL与ICDSC正相关(rho=0.6223,p=0.0005)。
  • COVID-19组谵妄(ICDSC≥4)患者GFAP、UCH-L1、NfL升高,ICU对照组无此关联。
  • COVID-19患者中呼吸功能指标或细胞因子与GFAP、总tau、UCH-L1、NfL水平无关联。

证据类型、等级与局限

  • 证据类型:前瞻性观察性研究(多中心ICU)。
  • 局限性:原文未述局限性。

对床旁实践的改变

  • 在COVID-19危重呼吸衰竭患者中,血浆GFAP、UCH-L1、NfL升高可能提示谵妄风险,但该研究为观察性、样本量小,尚不能作为床旁常规决策依据。
  • 上述标志物升高独立于呼吸功能和外周细胞因子,提示神经损伤可能不单纯由呼吸衰竭或全身炎症驱动,但原文未建议据此改变镇静或谵妄管理策略。

指南或共识出处

  • 原文未提及

以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。

英文原文(摘要)· 点击展开

OBJECTIVES: To provide an objective characterization of acute neurologic injury in critically ill patients with coronavirus disease 2019.

DESIGN: Prospective observational study. Demographics, comorbidities, and daily clinical physiologic and laboratory data were collected. Plasma levels of neurofilament-light chain, total tau, ubiquitin carboxy-terminal hydrolase L1, and glial fibrillary acidic protein were measured. The primary neurologic outcome was delirium defined by the Intensive Care Delirium Screening Checklist (scale 1-8). Associations among plasma biomarkers, respiratory failure, and inflammation were analyzed.

SETTING: Multicenter study in ICUs.

PATIENTS: Critically ill patients with respiratory failure, with coronavirus disease 2019, or without (ICU control).

MEASUREMENTS AND MAIN RESULTS: A total of 27 patients with coronavirus disease 2019 and 19 ICU controls were enrolled. Compared with ICU controls with pneumonia of other etiology, patients with coronavirus disease 2019 had significantly higher glial fibrillary acidic protein (272 pg/mL [150-555 pg/mL] vs 118 pg/mL [78.5-168 pg/mL]; p = 0.0009). In coronavirus disease 2019 patients, glial fibrillary acidic protein (rho = 0.5115, p = 0.0064), ubiquitin carboxy-terminal hydrolase L1 (rho = 0.4056, p = 0.0358), and neurofilament-light chain (rho = 0.6223, p = 0.0005) positively correlated with Intensive Care Delirium Screening Checklist score and were increased in patients with delirium (Intensive Care Delirium Screening Checklist ≥ 4) in the coronavirus disease 2019 group but not in ICU controls. There were no associations between the measures of respiratory function or cytokines with glial fibrillary acidic protein, total tau, ubiquitin carboxy-terminal hydrolase L1, or neurofilament-light chain levels in patients with coronavirus disease 2019.

CONCLUSIONS: Plasma glial fibrillary acidic protein is two-fold higher in critically ill patients with coronavirus disease 2019 compared with ICU controls. Higher levels of glial fibrillary acidic protein, ubiquitin carboxy-terminal hydrolase L1, and neurofilament-light chain associate with delirium in patients with coronavirus disease 2019. Elevated plasma glial fibrillary acidic protein, ubiquitin carboxy-terminal hydrolase L1, and neurofilament-light chain are independent of respiratory function and peripheral cytokines.

来源:Crit Care Explor,查看原文。版权归原作者所有。

参考来源

  1. Cooper J, Stukas S, Hoiland RL, et al. Quantification of Neurological Blood-Based Biomarkers in Critically Ill Patients With Coronavirus Disease 2019. Crit Care Explor. 2020. PMID: 33063038. doi:10.1097/CCE.0000000000000238

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。